Natural killer T cells promote collagen-induced arthritis in DBA/1 mice

Biochemical and Biophysical Research Communications

Volumn 390, Issue 3, 2009, Pages 399-403

  Jung, Sundo ^a   Shin, Hyun suk ^a   Hong, Changwan ^a   Lee, Hyunji ^a   Park, Yoon Kyung ^a   Shin, Jung Hoon ^a   Hong, Seokmann ^b   Lee, Gap Ryol ^c   Park, Se Ho ^a  

^a Korea University   (South Korea)

^b Sejong University   (South Korea)

^c Sogang University   (South Korea)

Author keywords

Autoimmune disease; CIA; IL 17; NKT cells; Th1 Th2 balance

Indexed keywords

COLLAGEN TYPE 2; CYTOKINE; INTERLEUKIN 17;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD1D; ARTHRITIS, EXPERIMENTAL; CYTOKINES; INTERLEUKIN-17; LYMPHOCYTE COUNT; MICE; MICE, INBRED DBA; MICE, MUTANT STRAINS; NATURAL KILLER T-CELLS;

MUS;

EID: 70449718748     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.09.008     Document Type: Article

References (26)

1. Courtenay J.S., Dallman M.J., Dayan A.D., Martin A., and Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 283 (1980) 666-668
2. Zanelli E., Gonzalez-Gay M.A., and David C.S. Could HLA-DRB1 be the protective locus in rheumatoid arthritis?. Immunol. Today 16 (1995) 274-278
3. Trentham D.E., Townes A.S., and Kang A.H. Autoimmunity to type II collagen an experimental model of arthritis. J. Exp. Med. 146 (1977) 857-868
4. Ortmann R.A., and Shevach E.M. Susceptibility to collagen-induced arthritis: cytokine-mediated regulation. Clin. Immunol. 98 (2001) 109-118
5. Miossec P., and van den Berg W. Th1/Th2 cytokine balance in arthritis. Arthritis Rheum. 40 (1997) 2105-2115
6. Bendelac A., Rivera M.N., Park S.H., and Roark J.H. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15 (1997) 535-562
7. Bendelac A., Lantz O., Quimby M.E., Yewdell J.W., Bennink J.R., and Brutkiewicz R.R. CD1 recognition by mouse NK1+ T lymphocytes. Science 268 (1995) 863-865
8. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., and Taniguchi M. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278 (1997) 1626-1629
9. Mars L.T., Novak J., Liblau R.S., and Lehuen A. Therapeutic manipulation of iNKT cells in autoimmunity: modes of action and potential risks. Trends Immunol. 25 (2004) 471-476
10. Van Kaer L. Natural killer T cells as targets for immunotherapy of autoimmune diseases. Immunol. Cell Biol. 82 (2004) 315-322
11. Chiba A., Oki S., Miyamoto K., Hashimoto H., Yamamura T., and Miyake S. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide. Arthritis Rheum. 50 (2004) 305-313
12. Chiba A., Kaieda S., Oki S., Yamamura T., and Miyake S. The involvement of V(alpha)14 natural killer T cells in the pathogenesis of arthritis in murine models. Arthritis Rheum. 52 (2005) 1941-1948
13. Kim H.Y., Kim H.J., Min H.S., Kim S., Park W.S., Park S.H., and Chung D.H. NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor beta1 production. J. Exp. Med. 201 (2005) 41-47
14. Miellot A., Zhu R., Diem S., Boissier M.C., Herbelin A., and Bessis N. Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway. Eur. J. Immunol. 35 (2005) 3704-3713
15. Ohnishi Y., Tsutsumi A., Goto D., Itoh S., Matsumoto I., Taniguchi M., and Sumida T. TCR Valpha14 natural killer T cells function as effector T cells in mice with collagen-induced arthritis. Clin. Exp. Immunol. 141 (2005) 47-53
16. Feldmann M., Brennan F.M., and Maini R.N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14 (1996) 397-440
17. Aarvak T., Chabaud M., Miossec P., and Natvig J.B. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J. Immunol. 162 (1999) 1246-1251
18. Hong C., and Park S.H. Application of natural killer T cells in antitumor immunotherapy. Crit. Rev. Immunol. 27 (2007) 511-525
19. Kaieda S., Tomi C., Oki S., Yamamura T., and Miyake S. Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis. Arthritis Rheum. 56 (2007) 1836-1845
20. Michel M.L., Keller A.C., Paget C., Fujio M., Trottein F., Savage P.B., Wong C.H., Schneider E., Dy M., and Leite-de-Moraes M.C. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204 (2007) 995-1001
21. Pichavant M., Goya S., Meyer E.H., Johnston R.A., Kim H.Y., Matangkasombut P., Zhu M., Iwakura Y., Savage P.B., DeKruyff R.H., Shore S.A., and Umetsu D.T. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J. Exp. Med. 205 (2008) 385-393
22. Chu C.Q., Swart D., Alcorn D., Tocker J., and Elkon K.B. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17. Arthritis Rheum. 56 (2007) 1145-1151
23. Kai H., Shibuya K., Wang Y., Kameta H., Kameyama T., Tahara-Hanaoka S., Miyamoto A., Honda S., Matsumoto I., Koyama A., Sumida T., and Shibuya A. Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice. Immunology 118 (2006) 233-239
24. Galli G., Nuti S., Tavarini S., Galli-Stampino L., De Lalla C., Casorati G., Dellabona P., and Abrignani S. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 197 (2003) 1051-1057
25. Lang G.A., Exley M.A., and Lang M.L. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner. Immunology 119 (2006) 116-125
26. Michel M.L., Mendes-da-Cruz D., Keller A.C., Lochner M., Schneider E., Dy M., Eberl G., and Leite-de-Moraes M.C. Critical role of ROR-gammat in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc. Natl. Acad. Sci. USA 105 (2008) 19845-19850